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SUMMARY – Stress ulcer prophylaxis is associated with bacterial colonization of respiratory 
tract. The aims of our study were to determine risk factors for trachea colonization (TC), colonization 
of pharynx (CP) or stomach (CD) and hospital-acquired pneumonia (HAP), and divide the factors 
into those with high risk and low risk. The study population (ventilated intensive care unit (ICU) 
patients eligible to receive stress ulcer prophylaxis) was randomized to receive one of three different 
treatment protocols: ranitidine, sucralfate, and no stress ulcer prophylaxis (control group). Clinical 
data relative to pre-specified risk factors for TC or HAP were recorded, as follows: APACHE II score 
(second risk factor), duration of intubation or tracheotomy (third risk factor), duration of mechanical 
ventilation (fourth risk factor) and duration of hospitalization in the ICU (fifth risk factor). Gastric 
pH was recorded and microbiological data regarding stomach, pharynx and trachea were collected on 
the 1st, 2nd, 3rd and 5th day. Fifty-eight out of 81 patients developed HAP (including ventilator-associ-
ated pneumonia), which occurred later in patients with gastric content pH <4 or those that were tra-
cheotomized. Stress ulcer prophylaxis was not associated with HAP; however, it was proved as a risk 
factor for TC. TC was detected in tracheotomized patients and was caused by gram-negative patho-
gens. CP was associated with TC, since the majority of patients had CP before TC. A combination of 
risk factors (APACHE II >18, age >65, mechanical ventilation and sedation) caused a higher inci-
dence of HAP and lower incidence of TC. HAP was more frequent in patients staying in the ICU for 
>10 days and those with cardiovascular disease as the underlying disorder. Sedation and previous an-
tibiotic therapy correlated with longer latent period (LAT), while higher values of gastric content pH 
were related to shorter LAT. The longest LAT was found in patients colonized with Acinetobacter spp. 
Risk factors that accelerated the occurrence of HAP were found to have caused previous colonization. 
A combination of risk factors increased the likelihood of TC and HAP, and shortened LAT between 
TC and HAP.
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Introduction
Stress ulcer prophylaxis has traditionally been used 
as the prevention of upper gastrointestinal bleeding in 
critically ill patients. A randomized trial comparing 
patients receiving prophylaxis against stress ulcers and 
those with no prophylaxis indicated that the use of 
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prophylaxis prevented clinically important gastroin-
testinal bleeding. On the other hand, the study sug-
gested the higher gastric pH to be associated with bac-
terial growth in intestinal tract, tracheobronchial colo-
nization, and nosocomial pneumonia1. In the past, it 
was shown that the agents that raise gastric pH may 
promote proliferation of bacteria in the stomach, par-
ticularly gram-negative bacilli that may originate in 
the duodenum. Passive esophageal reflux and micro-
aspiration of the gastric content along the endotra-
cheal tube may lead to colonization of the trachea and 
then to pneumonia2.
Nosocomial or hospital-acquired pneumonia (HAP) 
is defined as an infection of lower respiratory tract, 
which was not present in the emergency room but 
emerged 48 hours after hospital admission3. HAP is 
one of the most common nosocomial infections in the 
intensive care unit (ICU). It occurs in 5 to 10 per 1000 
admitted patients, and is up to 20 times more frequent 
in patients with mechanical ventilation (MV), mainly 
known as ventilator-associated pneumonia (VAP)4. 
HAP that occurs in patients on MV is divided into 
early HAP (48 hours to 4 days of MV), which is usu-
ally primary endogenous, or late HAP occurring after 
4 days of MV and is typically secondary endogenous 
or exogenous4,5. HAP prolongs hospital stay by 4-9 
days; mortality is 33%-50%, and even higher in pa-
tients infected with Staphylococcus aureus, Pseudomonas 
spp., Acinetobacter spp., Klebsiella pneumoniae, and En-
terobacter spp. (45%-71%)3,6,7. Microorganisms that 
colonize the pharynx and trachea can come from di-
gestive tract (endogenous route) or outer environment 
(exogenous route). Previous colonization of upper di-
gestive system is the main cause of HAP8,9. Digestive 
system colonization may occur due to migration of 
bacteria from the environment or reproduction of bac-
teria from intestinal flora10,11. Patients that are intu-
bated, tracheotomized or MV have a greater possibil-
ity of ascending pharyngeal colonization and subse-
quent colonization of trachea (TC) is thus easier. Mi-
croorganisms that colonize the stomach will gradually 
colonize the pharynx and frequently come in the respi-
ratory tract with aspirations and cause pneumonia12,13.
Thus, TC is the main source of HAP. It is present 
before the onset of pneumonia in 80% of patients14-16. 
Literature offers a vast knowledge about risk factors 
for HAP, but less about TC in ICU patients. The inde-
pendent risk factors include intubation, tracheotomy, 
MV, impaired consciousness, Acute Physiology and 
Chronic Health Evaluation II (APACHE II) score 
>16, and feeding through nasogastric tube17-20. The 
question is whether these factors and what combina-
tion of factors influence the occurrence of TC. There 
are scarcely any literature data on the relationship of 
risk factors and temporal occurrence of TC and HAP, 
and on the impact of risk factors and time between TC 
and HAP (latency time, LAT). Knowing these facts, 
we could differentiate patients at a high or low risk of 
the occurrence of TC and HAP. The data obtained 
could suggest whether the risk of TC means an equal 
risk of HAP.
The objectives of this study were to evaluate pa-
tients on stress ulcer prophylaxis at the highest risk of 
both bleeding and pneumonia and to determine which 
factors influence TC in these ICU patients. We tried 
to find a causal link between the number of risk factors 
and the occurrence of colonization and HAP, and to 
determine LAT between colonization and HAP. Thus, 
we tried to classify the risk factors into those asso-
ciated with a high risk and those less likely to cause 
TC or HAP.
Material and Methods
Inclusion and exclusion criteria
The study was designed as a randomized trial and 
lasted for 10 years, but data were analyzed retrospec-
tively. Ethics Committee of the Republic of Slovenia 
approved the study design and was run under register 
02/03/98. The study included ICU patients that were 
hospitalized, intubated, tracheotomized, or were on 
MV, and received protection against stress ulcers. The 
criteria for patient inclusion were expected duration of 
hospitalization in the ICU for at least 24 hours and 
age >15 years. Only patients with nasogastric tube that 
were intubated or tracheotomized participated in the 
study. Exclusion criteria for patients were the presence 
of HAP at admission to the ICU, immunocompro-
mised patients or leukopenia (less than 2x109/L), aspi-
ration at admission, previous intake of antacids, H2 
blockers or sucralfate (in the previous 24 hours) and 
visible bleeding from the stomach or duodenum (Fig. 
1). Termination of the experiment was set at the occur-
rence of HAP, removal of tube or cannula, 72 hours 
after discharge from the ICU, hospital death, or 21 
days of hospitalization.
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Participants and data collection
A total of 1054 patients were admitted to the med-
ical ICU. Of all eligible patients during the study pe-
riod, 154 were randomly assigned to a final group and 
were eventually intubated or tracheotomized for more 
than 24 hours. In accordance with inclusion criteria, 
81 patients could be analyzed. The patients were ran-
domly divided into specified groups using the method 
of randomized numbers. All patients had equal oppor-
tunity to be selected into the control group as the im-
pact of systematic factors on the choice was avoided. 
Of these patients, group 1 included patients treated 
with sucralfate (6 g/24 h; 26 patients) (first risk factor 
for TC/HAP) and group 2 patients were administered 
ranitidine, a histamine H2-receptor blocker (300 
mg/24 h; 27 patients). Ranitidine was administered in 
the form of tablets, 150 mg/12 h, which ensured at 
least 50% reduction in gastric acid secretion. When 
macroscopic bleeding was visible, patients received ra-
nitidine parenterally. Sucralfate was prescribed only in 
the form of granules, 4 to 6 times a day. Meanwhile, 28 
patients were selected as controls. The severity of pa-
tient condition was evaluated by APACHE II score 
(second risk factor). We recorded the duration of intu-
bation and tracheotomy (third risk factor), duration of 
MV (fourth risk factor) and duration of ICU hospital-
ization (fifth risk factor).
Clinical monitoring of patients
The patients were fully checked at admission, and if 
necessary the medical history and clinical picture from 
the admission department was completed. During 
testing, we routinely measured vital functions every 3 
hours (heart rate, respiration, temperature, blood pres-
sure, intake and excretion of fluids, oxygen saturation) 
and controlled laboratory values (complete blood 
count, C-reactive protein, electrolytes, hepatogram, ar-
terial blood gas measurement). The pH value of stom-
ach content was measured in the morning on an emp-
ty stomach, using a Universal Indicator pH-meter 
(Merck, Germany) with a range of 1 to 10. The pres-
ence of blood in the stomach aspirate was determined 
each morning using the Hemdetect reagent (DIPRO, 
Austria). Bleeding was established as the presence of 
fresh blood or blood mass in the stomach aspirate (or 
melena), or with positive hematest.
Criteria for diagnosis
Colonization of trachea and HAP were diagnosed 
according to the Center for Disease Control (CDC) 
criteria, as follows: presence of microorganisms in the 
tracheobronchial aspirates in at least one sample and 
presence of clinical and laboratory signs for HAP, or 
presence of the same microorganism in 2 consecutive 
isolates without clinical signs for HAP21. Since pneu-
monia after mechanical ventilation (ventilator associ-
ated pneumonia, VAP) is acquired in hospital units, we 
defined VAP patients as part of the HAP group.
Criteria for HAP were as follows: criterion I was 
physical examination for chest percussion or hypopho-
nesis and one of the following: purulent sputum (pres-
ence of >25 leukocytes and <10 epithelial cells in the 
Fig. 1. Work flow of experimental design  
and group distribution.
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visual field), positive hemoculture, isolation of micro-
organisms from aspirate or bronchoalveolar lavage 
(BAL), biopsy. Criterion II were positive patchy infil-
trations on chest x-ray and one of the following: puru-
lent sputum, positive hemoculture, isolation of micro-
organisms from aspirate or BAL, biopsy and histology. 
All patients also had to have elevated leukocyte values 
(>10x109/L) and elevated body temperature (>38 °C) 
considered as diagnosing criteria.
Bacteriological monitoring to confirm pneumonia
Samples for microbiological examination were ob-
tained in the morning on days 1, 2, 3 and 5, and then 
every 48 hours. Gastric juice was collected by nasogas-
tric tube. Blind profound aspiration of trachea and 
non-bronchoscopic BAL were the basic methods for 
gathering material for microbiological determination 
of TC or HAP. When the samples were unrepresenta-
tive, we repeated sampling using bronchoscope. Sam-
ples were sent for cultivation on blood, chocolate, Mc-
Conkey agar and thioglycolate broth. Latency time in 
days between TC and pneumonia was established with 
confirmation of the same bacterial culture from tra-
chea and lungs. Colonization was determined at three 
different sites, i.e. stomach, pharynx and trachea. 
When the same microorganism was isolated from the 
lung sample and colonizing site, the infectious route 
was determined.
Statistical analysis
Statistical analysis was performed by SPSS 21 soft-
ware (IBM, New York, USA). Univariate analysis 
compared continuous variables by Student’s t-test for 
data that were normally distributed, or by Wilcoxon 
rank sum test for abnormal distribution of variables. 
The χ2-test was used for evaluation of categorical vari-
ables. Statistical differences were considered to be sig-
nificant at p<0.05. Logistic regression revealed the 
impact of a combination of variables (risk factors) on 
the occurrence of colonization, HAP and LAT. More-
over, Hosmer-Lemeshov test assessed the influence of 
independent variables (risk factors) on the dependent 
variable (colonization). The effect of risk factors on la-
tency was shown by the Cox model analysis.






(n=28) Total (N=81) p-value
Gender (F/M) 18/8 21/6 24/4 63/18 (77.8%/22.2%) 0.5
Age (years), median 67.1 68.8 74.2 70.2 0.2
Intubated 19 19 22 60 (74.1%) 0.3
Tracheotomized 7 8 6 21 (25.9%) 0.3
MV 15 16 21 52 (64.2%) 0.4






























Relaxation 14 12 12 38 (46.9 %) 0.9
Sedation 27 21 22 70 (86.4 %) 0.2
Previous antibiotic treatment 7 7 3 17 (21 %) 0.2
pH value of gastric juice** 3.8 (3-5.2) 4.8 (4.2-6.3) 4.2 (3-6.5) 4.3 (3-6.5) **
F/M = female/male; MV = mechanical ventilation; APACHE = Acute Physiology and Chronic Health Evaluation; *febrile state, polyra-
diculoneuritis; **statistically significant difference (p=0.002) was found between sucralfate (S) and ranitidine (R) groups; comparison of 
patients who did not receive protection to those receiving S or R showed no statistical difference (p=0.3); comparison of control group and 
S group showed a statistically significant difference (p=0.03) in pH values.
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Results
Demographic data
At randomization, no statistically significant dif-
ference was found among the three groups in terms of 
patient characteristics and other underlying character-
istics (Table 1). In addition, no statistically significant 
difference was found among the three groups in the 
number of patients at risk with intubation (p=0.3), tra-
cheostomy (p=0.3) or mechanical ventilation (p=0.4) 
(Table 1). The median stay at ICU for all 81 patients 
was 38.4 days. APACHE II <16 was recorded in five 
(6.2%), APACHE II 16-20 in 53 (65.4%) and 
APACHE II >20 in 23 (28.4%) patients. In total, 
bleedings were determined in 18 (22.2%) patients. 
Most of these were microbleedings, while serious 
bleeding occurred in one patient from the sucralfate 
group. More bleedings were noticed in sucralfate group 
as compared with ranitidine group, but the difference 
was not statistically significant (p=0.4). Moreover, in 
the control group (no prophylaxis against stress ulcer), 
no bleedings were noticed compared to the other two 
groups, and a higher gastric juice pH was recorded 
compared to ranitidine group (Table 1).
Colonization of stomach, pharynx and trachea
Colonization of stomach (CS) occurred in 59 
(82.8%) patients, mostly on days 2 and 3 after inclu-
sion in the study (38 patients, 64.3%), less on day 4 or 
5 (13 patients, 22.1%). The median time to CS was 3.2 
(range 1-9) days. The most common bacteria that col-
onized digestive system are presented in Table 2. Col-
onization of pharynx (CP) was recorded in 37 (45.7%) 
patients and occurred later. On days 2 and 3, coloniza-
tion was detected in 15 (40.5%) patients, and on days 
4 and 5 in 14 (37.8%) patients. Early colonization (day 
1) was observed in two (5.4%) patients. The median 
time was 4.2 (range 1-15) days. TC occurred in 53 
(65.4%) patients, mostly on days 2 and 3, or on days 4 
and 5 (18 (34%) patients both). Between days 6 and 7, 
colonization occurred in seven (13.2%) patients, early 
colonization was found in two (3.8%) patients and late 
colonization (after day 7) in eight (14.1%) patients. 
The median time was 4.96 (range 1-18) days. Patients 
Table 2. Causative pathogens for colonization of the stomach (CS), pharynx (CP) and trachea (TC)
Microorganism CS (%) CP (%) TC (%) Total (%)
Pseudomonas aeruginosa 4 (6.8) 4 (0.8) 6 (11.3) 14
Acinetobacter calcoaceticus - 16 (16.2) 7 (13.2) 23
Klebsiella pneumoniae 9 (15.3) 3 (8.1) 6 (11.3) 18
Klebsiella spp. 9 (15.3) 2 (5.4) 2 (3.8) 13
Escherichia coli 10 (16.9) 7 (18.9) 3 (5.7) 20
Enterobacter spp. 9 (15.3) 3 (8.1) 7 (13.2) 19
Citrobacter spp. 1 (1.7) 1 (2.7) - 2
Serratia spp. - 1 (2.7) - 1
Haemophilus influenzae - - 1 (1.9) 1
Gram-negative 42 37 32 111 (69.8)
Staphylococcus aureus 3 (5.1) 8 (21.6) 11 (20.8) 22
MRSA - 1 (2.7) 1 (1.9) 2
Streptococcus faecalis 5 (8.5) - - 5
Streptococcus faecium 1 (1.7) - - 1
Streptococcus pneumoniae - - 5 (9.4) 5
Streptococcus spp. 2 (3.4) - - 2
Gram-positive 11 9 17 37 (23.3)
Candida albicans 2 (3.4) - 1 (1.9) 3 (1.9)
Candida spp. 4 (6.8) 1 (2.7) 3 (5.7) 8 (5.0)
Total 59 (37.1) 47 (29.6) 53 (33.3) 159 (100)
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with higher gastric juice pH (pH ≥4; n=56) were more 
frequently colonized than patients with lower gastric 
juice pH (pH <4; n=25) (Fig. 2), but CS or TC did not 
differ between the groups. The colonization and time 
of colonization onset were not associated with differ-
ent stress ulcer prophylaxis (p=0.6 and p=0.07, respec-
tively) (Fig. 3).
Development of hospital-acquired pneumonia
Fifty-eight (71.6%) patients developed HAP, 
which mostly occurred on days 6 and 7 (≈6.4). Seven-
teen (29.8%) patients developed pneumonia on days 4 
and 5, slightly less between days 6 and 7 (15 patients, 
26.3%). In ten (17.6%) patients, HAP emerged on 
days 8-9. Seven (12.3%) patients developed HAP be-
tween day 10 and day 14. Seventeen (29.3%) of 58 
HAP patients and four (18.2%) of 22 non-HAP pa-
tients died. The occurrence of HAP was not associated 
with different stress ulcer prophylaxis either (p=0.8) 
(Fig. 4).
Causative pathogens of HAP are presented in 
 Table 3. Previous association of pneumonia with colo-
nization of digestive system, pharynx or trachea was 
demonstrated in 36 (62.1%) of 58 patients. Mean-
Fig. 2. Colonization of the stomach (CS) and trachea (TC) according to gastric juice pH value.
Fig. 3. Pattern of tracheal colonization in patients receiving sucralfate (S), 
ranitidine (R) and control group (C).
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while, 22 HAP patients had no connection with previ-
ous colonization. Previous TC was recorded in 34 
(58.6%) patients; in 15 (41.7%) of them, a direct link 
between previous TC and HAP was established. Fur-
thermore, an infectious route of the same bacteria from 
CP to TC and finally to HAP was found in eight 
(22.2%) patients. Moreover, in six (16.7%) patients, we 
proved endogenous route of lower respiratory infec-
tion with isolation of bacteria from the stomach first, 
and then from the pharynx to trachea and to pneumo-
nia. A more accurate route is illustrated in Table 4. The 
connection between CS and TC was important; 30 out 
Fig. 4. Pattern of hospital-acquired pneumonia in patients receiving sucralfate 
(S), ranitidine (R) and control group (C).
Table 3. Isolated pathogens causing hospital-acquired pneumonia and correlation to previous colonization of trachea, 
pharynx or stomach
Microorganism HAP




mean time in days/(range)
Pseudomonas aeruginosa 13 (7.0)/(3-12) 6 (46) 1.8 (1-3)
Klebsiella pneumoniae 8 (6.4)/(4-10) 6 (75) 4.8 (4-5)
Klebsiella spp. 4 (7.3)/(6-9) 4 (100) 2.8 (1-4)
Enterobacter spp. 5 (6.8)/(4-12) 5 (100) 3.6 (2-8)
Acinetobacter calcoaceticus 4 (10.8)/(8-16) 4 (100) 4.8 (4-5)
Haemophilus influenzae 4 (3.8)/(3-5) 1 (25) 1.0 (1)
Escherichia coli 2 (8.0)/(8) 1 (50) 5.0 (5)
Proteus mirabilis 1 (3)/(3) 0 0
Gram-negative 41 (7.5)/(3-16) 27 (65.9) 2.9 (1-6)
Staphylococcus aureus 10 (5.5)/(3-11) 7 (70) 2.9 (1-5)
MRSA 2 (5.5)/(4-7) 1 (50) 2.0 (2)
Streptococcus pneumoniae 2 (3.0)/(3) 1 (50) 2.0 (2)
Gram-positive 14 (5.9)/(3-11) 9 (64.3) 2.7 (1-5)
Total 55 (7.1)/(3-16) 36 (65.5) 2.8 (1-6)
HAP = hospital-acquired pneumonia; LAT = latency time between colonization and development of pneumonia; MRSA = methicillin 
resistant Staphylococcus aureus
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of 53 patients with TC had previous CP (95% CI: 
1.27-12.4; p=0.01). The median LAT between the oc-
currence of colonization and pneumonia was 2.9 (1-6) 
days.
Acinetobacter and Pseudomonas were associated with 
TC, compared to other causative pathogens (p=0.003). 
In contrast to the aforementioned tests, Acinetobacter 
baumannii had the longest LAT (4.6 days) compared 
to other pathogens (LAT=2.7 days; p=0.010). The lon-
gest time for HAP was also observed with that bacte-
rium (10.8 days; p=0.010). In our experiment, Acineto-
bacter baumannii was closely associated with the devel-
opment of HAP. The duration of LAT between gram-
negative and gram-positive pathogens was not 
statistically different. The cases of pneumonia were 
mainly caused by Pseudomonas aeruginosa (23.6%) and 
Klebsiella pneumoniae (21.8%).
Besides stress ulcer prophylaxis, other risk factors 
that could affect TC were analyzed (Table 5). Tested 
variables showed that tracheotomy compared to intu-
bation represented an independent risk factor that 
stimulated TC (HR=14.9; p=0.017). Meanwhile, 34 of 
52 MV patients and 19 of 29 patients without MV 
had confirmed TC (p=0.8). Statistically significant dif-
ferences were recorded in the occurrence of HAP 
 between the two groups. HAP developed in 42 of 
52 MV patients and 16 of 29 non-MV patients 
(80.7% and 55.2%, respectively; p=0.03; 95% CI: 
1.11<HR<10.69). When comparing the two groups 
according to LAT, there was no significant difference. 
LAT was 2.9 days in the former group and 2.8 days in 
the latter group (p=0.7). Furthermore, the type of pro-
phylaxis against stress ulcer was not found to be an 
important risk factor (p=0.07) between the patients on 
Table 4. Route of colonization and occurrence of hospital-acquired pneumonia
Colonization HAP Causative pathogen Route LAT (days)
Stomach 6 Klebsiella pneumoniae (2) CS > CP > TC > HAP 3.0 (1-5)
 Klebsiella spp.   
 Escherichia coli   
 Enterobacter spp.   
 Staphylococcus aureus   
Stomach 5 Klebsiella pneumoniae (3) CS > TC > HAP 2.8 (1-5)
 Pseudomonas aeruginosa   
 Enterobacter spp.   
Stomach 2 Klebsiella spp. (2) CS > HAP 1.5 (1-2)
Pharynx 8 Acinetobacter calcoaceticus (2) CP > TC > HAP 3.8 (2-6)
 Staphylococcus aureus (2)   
 Pseudomonas aeruginosa (2)   
 Enterobacter spp.   
 MRSA   
Trachea 15 Staphylococcus aureus (4) TC > HAP 2.5 (1-5)
 Pseudomonas aeruginosa (3)   
 Acinetobacter calcoaceticus (2)   
 Enterobacter spp. (2)   
 Klebsiella pneumoniae   
 Klebsiella spp.   
 Haemophilus influenzae   
 Streptococcus pneumoniae   
No colonization* 22  HAP  
HAP = hospital-acquired pneumonia; CS = colonization of stomach; CP = colonization of pharynx; TC = colonization of trachea; LAT = 
latency time: *in 22 patients, no colonizing microorganism could be found at any site owing to effective multiple antibiotic therapy admin-
istered to patients after symptom onset
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ranitidine and sucralfate, but prophylaxis with raniti-
dine significantly contributed to TC (HR=9.42, 
p=0.026).
Assessing the effect of risk factors on LAT, seda-
tion of patients emerged as a stand-alone independent 
risk factor for shorter LAT (HR=0.11; p=0.053). Pa-
tients that were sedated had shorter LAT (Table 6). 
Moreover, gastric juice pH was associated with longer 
LAT (HR=2.63; p=0.011). Previous antibiotic therapy 
was associated with shorter LAT. The use of first gen-
eration cephalosporins prior to inclusion in the study 
was associated with sustained LAT (p=0.022). Other 
antibiotics did not significantly influence LAT.
Association of risk factors
All patients with APACHE II £18 and no under-
lying disease survived; on the other hand, 16 of 37 pa-
tients with APACHE II >18 and with underlying dis-
eases died (95% CI: 1.24<HR<1.73; p=0.009). When 
combining risk factors, we observed that a combina-
tion of APACHE II >18, age >65 and MV, or 
APACHE II >18, MV and sedation could both statis-
tically significantly predict HAP (p=0.010 and 
p=0.009, respectively). Death could only be predicted 
with a combination of APACHE II >18 and MV 
(p=0.020). APACHE II >18 had no influence on TC, 
although such patients had longer time to TC (3.25 vs. 
4.8 days, p=0.5). APACHE II showed correlation with 
HAP development. Five (45.5%) of 11 patients with 
lower score and 53 (75.7%) of 70 patients with higher 
score developed HAP (p=0.040). Furthermore, LAT 
was 1 day in the former group and 3 days in the latter 
group (p=0.009). Combined APACHE II >18 and in-
creased number of days on MV caused HAP (25 of 30 
patients, p=0.011), and more patients died (12 out of 
30, p=0.02) compared to patients with APACHE II 
>18 and without MV. If we add sedation as the third 
risk factor to our combination, the risk of HAP in-
creased from 25 to 31 of 41 patients (p=0.009) (Fig. 5). 
Furthermore, gram-negative bacteria caused coloniza-
tion more often in tracheotomized patients than in 
Table 6. Predictive values of risk factors with calculated 






Gender (male) -0.3774 0.6856 0.4888
Age 0.0172 1.0173 0.4834
Time in ICU 0.0053 1.0053 0.7228
APACHE II -0.2074 0.8127 0.1884
Intubation/tracheotomy 0.4217 1.5245 0.4217
Prophylaxis against  
stress ulcer 0.8792
S -0.1108 0.8951 0.8220
R -0.3446 0.7085 0.6123
Consciousness -0.3890 0.6777 0.5891
Sedation -2.1751 0.1136 0.0533
pH value 0.9685 2.6341 0.0111
MV (days) 0.7368 2.0893 0.3144
Previous antibiotics -3.2369 0.0393 0.0222
B = correlation coefficient; ICU = intensive care unit; MV = me-
chanical ventilation; S = sucralfate; R = ranitidine; APACHE = 
Acute Physiology and Chronic Health Evaluation
Table 5. Predictive values of risk factors with calculated 
hazard ratios (HR) for colonization of trachea (TC)
 B HR to predict TC p-value
Gender (male) 1.3905 4.0170 0.1909
Age 0.0431 1.0441 0.2013
Comorbidity -0.5657 0.5680 0.9416
Admission 
diagnosis: 0.4293
encephalitis 10.7813 481110.9820 0.9138
tetanus 13.9228 1113293.4000 0.8889
other 18.6115 121029757.0000 0.8777
Time in ICU -0.0140 0.9861 0.4794
APACHE II 0.1769 1.1935 0.4491
Intubation 





S 0.3512 1.428 0.7134
R 2.2426 9.4162 0.0264
Consciousness 0.9466 2.5770 0.5357
Sedation -1.1374 0.3207 0.5389
pH value 0.2336 1.2632 0.7114
MV (days) 0.2207 1.2469 0.2496
Previous 
antibiotics 0.6683 1.9510 0.3918
B = correlation coefficient; ICU = intensive care unit; MV = me-
chanical ventilation; S = sucralfate; R = ranitidine; APACHE = 
Acute Physiology and Chronic Health Evaluation
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intubated patients (95% CI: 0.02<HR<0.85; p=0.029), 
and in vulnerable and elderly patients (95% CI: 
0.00<HR<0.36; p=0.001).
Discussion
No relevant difference was recorded among the 
three randomization groups. Prophylaxis of stress ul-
cers did not influence the occurrence of CS or TC, but 
it was shown that higher gastric juice pH could lead to 
bacterial spread. However, Prod’hom et al.2 and Ed-
dleston et al.22 found that retrograde bacterial coloni-
zation from the stomach to the pharynx and trachea 
occurred more frequently in patients treated with ra-
nitidine than in those treated with sucralfate. The sec-
ond result section in our study presents results relative 
to the route of infection leading to HAP in the entire 
study population. The stomach, pharynx and tracheal 
colonization are relevant because it can lead to pneu-
monia. A relationship between TC and HAP was 
found, which is clinically useful. Secondly, the CS and 
CP support the hypothesis that these two anatomical 
regions act as bacterial reservoirs associated with the 
occurrence of TC or HAP. We assumed that the risk 
factors for colonization were similar to the risk factors 
that influence the occurrence of HAP, but they were 
not. Chevret et al.23 in their multicentre study found 
that significant risk factors for HAP were trauma, val-
ue of Simplified Acute Physiology Score (SAPS) >9, 
APACHE II >16, oxygen therapy with >50% oxygen, 
impaired respiratory reflexes, supported breathing and 
coma. In our study, we found factors such as APACHE 
II >18 and presence of MV. There was no difference in 
HAP between intubated and tracheotomized patients, 
but an important risk factor was tracheotomy that 
lasted for >3 days. Meanwhile, intubation time was not 
a risk factor for TC. This ratio indicated that trache-
otomized patients suffered from HAP later than intu-
bated patients. Similar was shown for MV that lasted 
for >3 days. In the past, MV was also confirmed as an 
independent risk factor for HAP24. Turković et al.25 
evaluated the impact of tracheotomy on VAP. Trache-
otomy was associated with a reduced duration of MV 
after VAP onset, but only if patients were tracheoto-
mized at the moment of VAP onset. According to 
some authors26,27, the risk may be higher in the first 5 
days of ventilation, when the incidence of HAP is usu-
ally higher. In our study, HAP was more common in 
the first 7 days after admission to the ICU, which co-
incided with the results of our previous trial28.
Hospital-acquired pneumonia affected 50% of pa-
tients that were tracheotomized for >3 days. With the 
addition of APACHE II >18 as a risk factor (two risk 
factors), there were no significant changes in the num-
ber of HAP patients. However, when we took into ac-
count the third risk factor (MV), the number of pa-
tients increased from 50% to 66.7%. Combined with 
the fourth risk factor (sedation), the percentage of pa-
tients that developed HAP increased to 79.6%. Thus, 
the risk of HAP increased with the increasing number 
of risk factors, similar to the results published by 
Chevret et al.23.
A similar study was conducted by Garrouste et al.29; 
they followed risk factors for the development of 
pneumonia in 86 MV patients. Statistically significant 
risk factors were parenteral nutrition and progressive 
underlying disease. Age, duration of hospitalization in 
the ICU, severity of any disease, immunosuppression 
or enteral nutrition, previous antibiotic therapy, or 
drugs against stress ulcer (ranitidine or sucralfate) did 
not have any effect on the occurrence of HAP. Com-
parable results were obtained in our study; HAP was 
not connected with age, time in the ICU, protection 
Fig. 5. Effect of combined risk factors on 
colonization of trachea (TC) and hospital-
acquired pneumonia (HAP).
APACHE = Acute Physiology and Chronic Health Evaluation; 
MV = mechanical ventilation; SED = sedation
I. Muzlovič and D. Štubljar Risk of tracheal colonization and nosocomial pneumonia
82 Acta Clin Croat, Vol. 58, No. 1, 2019
against stress ulcers, disturbance of consciousness, be-
cause it was present in most patients. Some authors30 
cite an underlying disease as an independent risk fac-
tor. We observed a similar pattern (but without statis-
tical significance), i.e. patients that developed HAP 
frequently had an underlying cardiovascular disease, 
whereas sex, age, admission diagnosis and relaxation 
did not affect the incidence of HAP.
Nevertheless, our results differ slightly from the 
data published by Beck-Sague et al.31 who found a sta-
tistically significant difference in the occurrence of 
HAP in MV patients receiving H2-receptor antago-
nists, oral intubated patients and those having previ-
ously received cefazolin. In our previous study28, the 
use of sucralfate or ranitidine had no significant im-
pact on the occurrence of HAP, as we similarly noted 
in the current research. Considering the fact that ele-
vation of gastric acid pH enables growth of gram-neg-
ative bacteria in the stomach, which then can reach the 
pharynx and lungs by aspiration, the risk of HAP 
would be greater if we apply a drug against stress ul-
cers, which raises gastric acid pH8,32,33. However, in our 
study, despite the difference in the gastric juice pH be-
tween sucralfate and ranitidine, the prophylaxis against 
stress ulcers did not play an important role in the oc-
currence of HAP. Otherwise the use of drugs against 
stress ulcers was previously proven as a factor for the 
occurrence of HAP in patients on MV34,35. Torres et 
al.36 and Bonten et al.37 included altered pH of gastric 
contents and the presence of nasogastric tube as ac-
celerating risk factors for CS. However, these factors 
did not influence TC. They concluded that gastric juice 
pH was not significantly different with the adminis-
tration of sucralfate or ranitidine, and CS was more 
common at higher pH values. Moreover, our research 
showed that the use of drugs was an independent risk 
factor for TC when applying sucralfate or ranitidine 
(p=0.03). The administration of sucralfate or absence 
of drugs did not affect the occurrence of TC, but tak-
ing ranitidine could predict TC, as confirmed by the 
fact that elevated gastric juice pH shortened LAT be-
tween TC and HAP. Although CS was slightly more 
common in patients with elevated pH (with the ad-
ministration of ranitidine), the levels of pH in our 
study did not affect the occurrence of TC.
Furthermore, Bonten et al.38 report that long-term 
MV was an independent risk factor for TC. A correla-
tion was also found with previous CP with the same 
microorganism. Microaspiration from colonized phar-
ynx can be the cause of ‘early pneumonia’ in patients on 
MV. In our study, no significant difference in the oc-
currence of TC was determined when intubation or 
tracheotomy was present. MV was not associated with 
the occurrence of TC. However, we found a connec-
tion with previous use of first-generation cephalospo-
rins. In these patients, the incidence of colonization 
was lower than in those without having previously 
taken cephalosporins. In patients with MV, CP repre-
sented a risk factor for ‘early pneumonia’, while previ-
ous use of broad-spectrum antibiotics a risk factor for 
“late pneumonia”5,39. Previous use of antibiotics in 
some trials increased the likelihood of HAP40-43. We 
found that patients having taken first-generation 
cephalosporins prior to inclusion in the study devel-
oped HAP significantly later than those having used 
no antibiotics.
Feldman et al.43 investigated colonization of upper 
and lower respiratory tract and concluded that coloni-
zation occurred very fast with microorganisms that 
later caused pneumonia. In our study, we recorded 
similar results. CS occurred between days 2 and 3 
(mean 3.2 days), CP between days 2 and 3 (mean 4.2 
days), and TC between days 2 and 5 (mean 4.95 days). 
Regarding LAT, we could conclude that stomach or 
pharynx were an important source of TC. The CP by 
Acinetobacter and Pseudomonas was often associated 
with TC (p=0.05). We also found that TC with Aci-
netobacter and Pseudomonas occurred later (p=0.003). 
TC was significantly more common in patients that 
had oropharyngeal colonization for more than 2 days, 
meaning that CP was an independent risk factor for 
late TC (p=0.04). The same was confirmed by Ewig et 
al.44 and Safdar et al.45, who concluded that coloniza-
tion of the upper respiratory system was an indepen-
dent risk factor for TC, and had greater probability for 
the occurrence of early HAP.
Oropharyngeal colonization by the gram-negative 
bacteria Pseudomonas and Acinetobacter has been prov-
en to be an independent risk factor for TC28,46,47. When 
comparing correlation of CP with microorganisms, 
the incidence of TC was significantly higher when the 
pharynx was colonized by Enterobacteriaceae, Pseudo-
monas and Acinetobacter (p=0.022). Chastre and 
Fagon47 emphasized the great importance of microor-
ganisms that colonized the upper respiratory tract for 
the emergence of HAP in patients on MV. In the 
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early period (the first week), the microorganisms in-
volved were Staphylococcus aureus, Streptococcus pneu-
moniae and Haemophilus influenzae. Later, these mi-
croorganisms were replaced by resistant microorgan-
isms such as Pseudomonas aeruginosa, MRSA and Aci-
netobacter baumannii. These microorganisms are 
probably the main cause of higher mortality. Similar 
findings were observed by Brusich et al.48, who found 
that gram-negative bacteria were the leading causative 
agents (82.03%) of VAP and were even multidrug-re-
sistant. Thus, we must also consider fungi, especially in 
immunocompromised patients49. Bonten et al.38 found 
shorter LAT in patients that had previous TC than in 
those that previously had only CP. Accordingly, pneu-
monia occurred later in infections by Pseudomonas ae-
ruginosa than by other gram-negative bacteria. In the 
present study, we found a significantly longer LAT for 
Acinetobacter infections (p=0.01) and slightly longer 
LAT for Pseudomonas aeruginosa (p=0.08) compared to 
other pathogens. The difference could be clinically rel-
evant. However, LAT was shorter when the same bac-
teria had previously colonized the trachea compared to 
previous CP. Although the results showed significantly 
longer LAT in patients with APACHE II >18, clini-
cally significantly longer LAT in tracheotomized ver-
sus intubated patients (p=0.09), and clinically shorter 
LAT in patients with higher pH of the stomach con-
tents (p=0.07), logistic regression analysis showed that 
the independent risk factors affecting LAT were only 
pH of gastric contents (p=0.01) and previous antibi-
otic treatment (p=0.020). Higher pH of gastric con-
tents was associated with shorter LAT, and secondly 
taking first-generation cephalosporins extended LAT. 
The use of broad-spectrum antibiotics affected the ini-
tial CP and thus prevented the development of pneu-
monia in the first 4 days, thus enabling late (generally 
after 4 days) colonization and infection by gram-neg-
ative pathogens. This could be in line with the fact that 
these patients usually acquired HAP caused by micro-
organisms that extend LAT. Moreover, our study 
found the rate of TC to be statistically lower in pa-
tients with gastric pH <4.0, suggesting that the benefi-
cial effect of sucralfate is essentially obtained in the 
group of patients able to maintain low gastric pH. Our 
results also agree with the results of a study2 that showed 
correlation between the microorganisms recovered 
from the lower respiratory tract and those from the 
stomach, but not with those found in the pharynx.
In our study, several limitations were observed. Our 
sample size was too small to make definite conclusions 
on the predictive values of specific risk factors for TC 
or HAP. Moreover, the selection of patients included 
in the study could be more representative, but it is dif-
ficult to gather a larger sample of appropriate and 
comparable patients for three test groups. Patients that 
are on MV, intubated or tracheotomized have already 
been staying at the ICU for quite a long time. 
However, our analysis of LAT between TC and HAP 
is a valuable add to the existing literature. To our 
knowledge, this is one of the rare studies to assess cor-
relation between different steps of infection in respira-
tory system, especially in recent literature. Therefore, 
our study represents an important update on this sub-
ject. We observed several steps of colonization which 
could be evaluated further in future studies in a larger 
sample size.
Conclusions
The problem of correlation between TC and HAP 
in this manner was processed for the first time and 
presented in this study. Risk factors that influenced 
HAP did not always influence TC. Risk factors that 
significantly worsened disease outcome (increased 
mortality) were identified as APACHE II >18, pres-
ence of heart and circulatory system disease as primary 
disease, previous use of antibiotics, and presence of 
MV. In most cases, HAP was preceded by TC. Higher 
gastric content pH was related to shorter LAT, and 
antibiotic therapy was an independent risk factor for 
longer LAT. The results of this trial deepen the knowl-
edge about HAP pathogenesis and suggest some pos-
sibilities for early prevention of hospital infections and 
rational use of antibiotics.
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Sažetak
PROFILAKSA STRESNOG ULKUSA KAO ČIMBENIK RIZIKA  
ZA KOLONIZACIJU TRAHEJE I BOLNIČKI STEČENU PNEUMONIJU  
KOD BOLESNIKA U JEDINICI INTENZIVNOG LIJEČENJA:  
UTJECAJ NA VRIJEME LATENCIJE ZA PNEUMONIJU
I. Muzlovič i D. Štubljar
Profilaksa stresnog ulkusa povezana je s bakterijskom kolonizacijom respiratornog trakta. Cilj našega istraživanja bio je 
utvrditi čimbenike rizika za kolonizaciju traheje (KT), ždrijela (KŽd) ili želuca (KŽe) i bolnički stečenu pneumoniju (BSP) 
te podijeliti čimbenike na one s visokim rizikom i niskim rizikom. Ispitivana populacija (bolesnici u jedinici intenzivnog 
 liječenja ( JIL) s ventilacijom koji imaju pravo na profilaksu stresnog ulkusa) randomizirani su za primjenu jedne od tri razli-
čite vrste liječenja: ranitidin, sukralfat i kontrolnu skupinu. Zabilježeni su klinički podaci u odnosu na unaprijed određene 
čimbenike rizika za kolonizaciju traheje ili BSP te APACHE II (drugi čimbenik rizika), trajanje intubacije ili traheotomija 
(treći čimbenik rizika), trajanje mehaničke ventilacije (četvrti čimbenik rizika) i trajanje hospitalizacije u JIL-u (peti čimbe-
nik rizika). Zabilježeni su želučani pH i prikupljeni su mikrobiološki podaci o želucu, ždrijelu i dušniku 1., 2., 3. i 5. dana. Od 
81 bolesnika BSP se razvila u njih 58 (uključujući upalu pluća povezanu s ventilatorom), i to kasnije u bolesnika s pH želu-
čanog sadržaja <4 ili onih koji su traheotomizirani. Profilaksa stresnog ulkusa nije bila povezana s BSP-om, no dokazana je 
kao čimbenik rizika za kolonizaciju traheje. Kolonizacija traheje je otkrivena kod bolesnika s traheotomijom, a bila je uzro-
kovana gram-negativnim patogenima. Kolonizacija ždrijela bila je povezana s kolonizacijom traheje, jer je većina bolesnika 
imala kolonizaciju ždrijela prije kolonizacije traheje. Kombinacija čimbenika rizika (APACHE II >18, dob >65 godina, 
mehanička ventilacija i sedacija) uzrokovala je veću učestalost BSP-a i manju učestalost kolonizacije traheje. BSP je bila češća 
u bolesnika koji su boravili u JIL-u >10 dana i onih s kardiovaskularnim bolestima kao temeljnim poremećajem. Sedacija i 
prethodna antibiotska terapija bile su u korelaciji s dužim latentnim razdobljem (LAT), dok su veće vrijednosti pH sadržaja 
želuca bile povezane s kraćim LAT. Najduži LAT pronađen je u bolesnika koloniziranih bakterijom Acinetobacter spp. Utvr-
đeno je da su čimbenici rizika koji su ubrzali pojavu BSP-a uzrokovali prethodnu kolonizaciju. Kombinacija čimbenika rizi-
ka povećala je vjerojatnost kolonizacije traheje i BSP-a te skratila LAT između kolonizacije traheje i BSP-a.
Ključne riječi: Želudac, ulkus; Bakterije – rast i razvoj; Bolnički stečena upala pluća; Jedinice za intenzivnu skrb; Rizični čim-
benici; Traheotomija
